[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369596-105":59,"doc-detail-369596-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","extracellular-vesicles-derived-from-mature-dendritic-cells-loaded-with-cdc1-specific-chemokine-xcl1-combined-with-chemotherapy-induced-icd-for-the-treatment-of-castration-resistant-prostate-cancer","Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancer","","Dendritic cell-derived extracellular vesicles are investigated as a nanovaccine platform to activate adaptive immunity against castration-resistant prostate cancer. The study overexpresses the cDC1 chemokine XCL1 in dendritic cells, generating extracellular vesicles (DEXXCL1) with enhanced chemotaxis, activation, and antigen-presenting capacity of cDC1 cells. In vitro and mouse model data show that combining DEXXCL1 with cisplatin-induced immunogenic cell death increases CD8+ T-cell numbers and cytotoxicity, remodels the tumor immune microenvironment, suppresses tumor growth, and prolongs survival.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/extracellular-vesicles-derived-from-mature-dendritic-cells-loaded-with-cdc1-specific-chemokine-xcl1-combined-with-chemotherapy-induced-icd-for-the-treatment-of-castration-resistant-prostate-cancer/369596/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/extracellular-vesicles-derived-from-mature-dendritic-cells-loaded-with-cdc1-specific-chemokine-xcl1-combined-with-chemotherapy-induced-icd-for-the-treatment-of-castration-resistant-prostate-cancer/369596.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main objective of the study?","Question",{"text":113,"@type":114},"To evaluate whether functional dendritic-cell-derived extracellular vesicles can produce antitumor efficacy in castration-resistant prostate cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How are the extracellular vesicles engineered and what key molecules are enhanced?",{"text":118,"@type":114},"XCL1 is overexpressed in mature dendritic cells so their extracellular vesicles highly express XCL1 and are enriched for CCR7 and MHC I, supporting stronger chemotaxis and antigen presentation by cDC1 cells.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the role of cisplatin and immunogenic cell death in the treatment strategy?",{"text":122,"@type":114},"Cisplatin induces immunogenic cell death that generates tumor-associated antigens, and the combination with the nanovaccine strengthens CD8+ T-cell proliferation and cytotoxic activity while reshaping the tumor immune microenvironment.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369596,1790328206,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Cancer Immunology, Immunotherapy (2025) 74:242 [https://doi.org/10.1007/s00262-025-04070-8](https://doi.org/10.1007/s00262-025-04070-8)  \nExtracellular vesicles derived from mature dendritic cells loaded with cDC1‑specific chemokine XCL1 combined with chemotherapy‑induced ICD for the treatment of castration‑resistant prostate cancer  \nZhongqiang Fan1 · Zhao Wang3 · Hui Zhang4 · Hao Zhang1 · Rui Zhao1 · Shimiao Zhu2 · Xiaoqiang Liu1  \nReceived: 12 January 2025 / Accepted: 26 April 2025 / Published online: 18 June 2025 © The Author(s) 2025  \nAbstract  \nBackground Dendritic cells (DCs) derived extracellular vesicles represent a promising vehicle for the activation of adaptive immunity, demonstrating significant potential in the development of cancer nanovaccines. The aim of this study was to evaluate the antitumor efficacy of a functional DCs-derived extracellular vesicles in castration-resistant prostate cancer. Methods A pre-modification strategy was employed to overexpress XCL1 in dendritic cells, enabling their extracellular vesicles to highly express XCL1 protein. In vitro experiments, prostate cancer-bearing mouse models, and OVA-expressing prostate cancer mouse models demonstrated that dendritic cells efficiently internalize extracellular vesicles derived from XCL1-overexpressing mature dendritic cells (DEXXCL1), thereby enhancing the chemotaxis, activation, and antigen-presenting capacity of cDC1 cells. When combined with the immunogenic cell death effect induced by cisplatin, this approach significantly increased the number and cytotoxic activity of CD8+ T cells, improved the tumor microenvironment, and effectively suppressed prostate cancer tumor growth.  \nResults The coding sequence of XCL1 successfully inserted upstream of the PDGFR transmembrane domain and transfected into dendritic cells, enabling their extracellular vesicles to highly express XCL1 protein. Extracellular vesicles derived from XCL1-overexpressing mature dendritic cells not only exhibited high XCL1 expression, but were also enriched with chemokine receptor CCR7 and MHC I molecules on their surface. This nanovaccines enhanced the uptake of extracellular vesicles by dendritic cells, recruited cDC1 cells within the tumor tissue, and significantly improved their antigen-presenting capacity. When combined with the immunogenic cell death effect induced by cisplatin, which generates a large amount of tumor-associated antigen STEAP1, this strategy effectively enhanced the proliferation and cytotoxic activity of CD8+T cells. Moreover, it reduced the proportion of regulatory T cells and immunosuppressive factors, thereby reshaping the tumor immune microenvironment. This approach effectively inhibited tumor growth in mice and prolonged their survival. These findings demonstrate the strong synergistic effects of the nanovaccines and cisplatin in promoting antitumor immunity. Conclusions A novel nanovaccines induces potent antitumor immune responses and, in combination with the chemotherapeutic agent cisplatin, effectively remodels the tumor immune microenvironment. This approach offers a new strategy and preclinical evidence for the immunotherapy of “cold tumors” prostate cancer.  \nKeywords Extracellular vesicles · XCL1 · Immunogenic cell death · Castration resistant prostate cancer · Nanovaccines · Dendritic cells  \nZhongqiang Fan, Zhao Wang and Hui Zhang have contribute equally to this work.  \nExtended author information available on the last page of the article  \nIntroduction  \nProstate cancer poses a significant global health challenge for men and is the most common malignancy among males in developed countries [1] . Early-stage localized lesions, when detected, can achieve satisfactory outcomes through surgical intervention, radiotherapy, or interventional  \ntherapies [2] . However, approximately 30% of patients experience biochemical recurrence, and one-third of these patients ultimately succumb to the disease [3] . Androgen deprivation therapy (ADT) has lo","cbCaipS3275J8tYd","https://ap.wps.com/l/cbCaipS3275J8tYd","pdf",4946722,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Epidemiology and treatment challenge in CRPC\n## Rationale for immunotherapy and “cold tumor” limitation\n## Role of XCL1 and dendritic cell-derived EVs in cDC1 recruitment","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To evaluate whether functional dendritic-cell-derived extracellular vesicles can produce antitumor efficacy in castration-resistant prostate cancer.\"},{\"question\":\"How are the extracellular vesicles engineered and what key molecules are enhanced?\",\"answer\":\"XCL1 is overexpressed in mature dendritic cells so their extracellular vesicles highly express XCL1 and are enriched for CCR7 and MHC I, supporting stronger chemotaxis and antigen presentation by cDC1 cells.\"},{\"question\":\"What is the role of cisplatin and immunogenic cell death in the treatment strategy?\",\"answer\":\"Cisplatin induces immunogenic cell death that generates tumor-associated antigens, and the combination with the nanovaccine strengthens CD8+ T-cell proliferation and cytotoxic activity while reshaping the tumor immune microenvironment.\"}]","Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancer | PDF",1790183610,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0c3548d887f6cf532b4fbad50e25b97.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5401984125a2b97ce34421177c00ef3b.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e25348c618225bea45bb241daf8de8ad.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/231e90f9f2e3c8689aaa483a8598e3e3.webp",980,1301]